Alpha Tau Medical (DRTS) Other financing activities (2021 - 2022)

Alpha Tau Medical (DRTS) posted Other financing activities of $1.9 million for Q2 2022, up 41.26% sequentially from $1.3 million in Q1 2022.

Alpha Tau Medical (DRTS) Other financing activities (2021 - 2022) Analysis & Trends

Alpha Tau Medical has reported Other financing activities for 2 years, with the latest figure at $1.9 million in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Alpha Tau Medical	1.32 Bn	1.32 Bn	-

Download Data